CPIX
Cumberland Pharmaceuticals Inc
$
3.490
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
3.530
Open
3.460
VWAP
3.48
Vol
28.06K
Mkt Cap
52.21M
Low
3.3612
Amount
97.51K
EV/EBITDA(TTM)
14.42
Total Shares
14.19M
EV
40.75M
EV/OCF(TTM)
5.72
P/S(TTM)
1.20
Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. Its portfolio of brands includes Acetadote (acetylcysteine) injection, for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) injection, for the treatment of pain and fever; Kristalose (lactulose) for oral solution, a prescription laxative, for the treatment of constipation; Sancuso (granisetron) transdermal, for the prevention of nausea and vomiting in patients receiving certain types of chemotherapy treatment; Vaprisol (conivaptan) injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; and Vibativ (telavancin) injection, for the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2021Q4
FY2022Q1
12.18M
+18.71%
0.060
+500%
0.00
-100%
0.000
-100%
Estimates Revision
Stock Price
Go Down
-30.62%
In Past 3 Month
1 Analyst Rating
Wall Street analysts forecast CPIX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CPIX is 3.50 USD with a low forecast of 3.50 USD and a high forecast of 3.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
1 Hold
0 Sell
Hold
Current: 3.490
Low
3.50
Averages
3.50
High
3.50
Current: 3.490
Low
3.50
Averages
3.50
High
3.50
The End
No Data
Valuation Metrics
The current forward P/E ratio for Cumberland Pharmaceuticals Inc (CPIX.O) is 0.00, compared to its 5-year average forward P/E of 7.20. For a more detailed relative valuation and DCF analysis to assess Cumberland Pharmaceuticals Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
7.20
Current PE
0.00
Overvalued PE
27.67
Undervalued PE
-13.27
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
4.94
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
24.70
Undervalued EV/EBITDA
-14.81
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
0.47
Current PS
0.00
Overvalued PS
1.00
Undervalued PS
-0.05
Financials
Annual
Quarterly
FY2025Q2
YoY :
+10.04%
10.84M
Total Revenue
FY2025Q2
YoY :
-27.20%
-747.48K
Operating Profit
FY2025Q2
YoY :
-33.32%
-735.21K
Net Income after Tax
FY2025Q2
YoY :
-37.50%
-0.05
EPS - Diluted
FY2025Q2
YoY :
-189.02%
803.40K
Free Cash Flow
FY2025Q2
YoY :
+0.97%
72.15
Gross Profit Margin - %
FY2025Q2
YoY :
-722.64%
16.50
FCF Margin - %
FY2025Q2
YoY :
-39.46%
-6.78
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
CPIX News & Events
Events Timeline
2025-08-04 (ET)
2025-08-04
09:08:47
Cumberland announces availability of Vibativo 4-Vial Starter Pak through Vizient
2025-06-23 (ET)
2025-06-23
09:10:42
Cumberland shares latest results from its Phase 2 FIGHT DMD trial
2025-05-13 (ET)
2025-05-13
16:15:45
Cumberland announces partnership with Qureight
Sign Up For More Events
Sign Up For More Events
News
9.5
08-06NASDAQ.COMCumberland (CPIX) Q2 Revenue Up 10%
9.5
08-06NewsfilterCumberland Pharmaceuticals Inc. (CPIX) Q2 2025 Earnings Call Transcript
9.5
08-05PRnewswireCumberland Pharmaceuticals Reports 23% Revenue Growth Year-to-Date
Sign Up For More News
People Also Watch
FAQ
What is Cumberland Pharmaceuticals Inc (CPIX) stock price today?
The current price of CPIX is 3.49 USD — it has increased 0.58 % in the last trading day.
What is Cumberland Pharmaceuticals Inc (CPIX)'s business?
What is the price predicton of CPIX Stock?
What is Cumberland Pharmaceuticals Inc (CPIX)'s revenue for the last quarter?
What is Cumberland Pharmaceuticals Inc (CPIX)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Cumberland Pharmaceuticals Inc (CPIX)'s fundamentals?
How many employees does Cumberland Pharmaceuticals Inc (CPIX). have?